$11.81
-3.0%Oaktree Specialty Lending Corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering, and media and advertising sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies with enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.
Chief Compliance Officer
Chief Executive Officer & Co-Chief Investment Officer
Co-Chief Investment Officer
MD,Chief Financial Officer & Treasurer
MD,General Counsel & Secretary
Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending
Managing Director of Origination
President
Senior Vice President
Senior Vice President & Head of Investor Relations
During the last 12 months, insiders have purchased $40K worth of OCSL shares, with no selling activity reported.
2.5K
26.93K
0
0.00
+27K
+$27K
0
0.00
0
0.00
+0
+$0
975
12.87K
0
0.00
+13K
+$13K
0
0.00
0
0.00
+0
+$0
Caldwell Phyllis R
Director
$40K
No selling activity
Strong bullish signal with $40K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
1 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Unanimous insider buying: Zero selling combined with active buying is rare and typically very bullish. Insiders appear to see significant upside with limited downside risk.
OCSL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | January 16, 2026 | March 03, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | January 08, 2026 | March 03, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | January 17, 2025 | March 04, 2025 | 2025 | |
DEF 14A DEF 14A 2025 N/A | January 10, 2025 | March 04, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | January 19, 2024 | March 04, 2024 | 2024 | |
DEF 14A DEF 14A 2024 N/A | January 10, 2024 | March 04, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | February 06, 2023 | March 17, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | January 20, 2022 | March 04, 2022 | 2022 | |
DEF 14A DEF 14A 2022 N/A | January 13, 2022 | March 04, 2022 | 2022 | |
DEF 14A DEF 14A 2020 N/A | January 13, 2020 | March 09, 2020 | 2020 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.